Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

摘要

Dithiomaleimide-based camptothecin-containing nanoparticles are designed to have exceptionally high drug loading and are capable of reduction-responsive, FRET-indicated drug release.

关键词